1 result(s) for LBH589 (Panobinostat)
| PI Name | Protocol # | Title |
|---|---|---|
| Joshi Alumkal | IRB00005364 | Phase I/II randomized trial of LBH589 (Panobinostat) at two dose levels combined with bicalutamide (Casodex®) in men with castration-resistant prostate cancer |
You may qualify for additional trials within our Phase 1 Program